Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's paroxetine
hydrochloride controlled-release 25 mg tablets to GSK's Paxil CR™ 25 mg tablets following a
single, oral 25 mg (1 x 25 mg) dose administered under fed conditions.